IFI-M · HCB Tri-Axis Dominant-Primary Series

Specimen SS-F-M3-00491 // MULTI-AXIS · IFI-M

HCB Tri-Axis Dominant-Primary Series IV-AG

Capsicum chinense

Habanero

Tier IVHCB Tri-Axis Dominant-Primary Series

Target Trait

2.38×

fold-change

Heat-dominant tri-axis C+B modulated fold-change

Technical Specifications

SKU

SS-F-M3-00491

Genomic Edits

11

GC Content

49.1%

Construct Length

6,157 bp

Promoter System

Tissue-specific 2A11

Expression System

Agrobacterium-mediated T-DNA

Host Strain

EHA105

Receptor Target

TRPV1 + TRPM8 + TAS2R38 (suppression)

IFI Score

238

Pathway Edits

  • TRPV1 pathway primary gene cluster for heat (IFI-H) tri-axis component
  • TRPM8 pathway primary gene cluster for cooling (IFI-C) tri-axis component
  • TAS2R38 (suppression) pathway primary gene cluster for bitter-attenuation (IFI-B) tri-axis component
  • Tri-axis metabolic flux partitioning hub for concurrent HCB pathway operation
  • Cross-pathway regulatory circuit for heat-dominant HCB triple-axis expression
  • Cofactor regeneration system (NADPH, ATP, acetyl-CoA) supporting triple-axis concurrent production

Key Interventions

Triple-axis receptor co-activation: TRPV1, TRPM8, and TAS2R38 (suppression) pathways simultaneously engineeredHeat-dominant tri-axis expression strategy (HCB) with cross-pathway flux managementT-DNA binary vector 2A11 for stable genomic integration of multi-axis construct stack

IFI Subscale Profile

IFI Profile

IFI-S
—
IFI-U
—
IFI-B
—
IFI-K
—
IFI-C
—
IFI-P
—
IFI-A
—
IFI-F
—

Use Case

Tier IV HCB triple-axis construct for advanced multi-modal sensory architecture combining heat, cooling, and bitter-attenuation axes. Suitable for ultra-premium ingredient formulation requiring certification across three simultaneous IFI receptor pathways.

License

$3999 · Tier IV License

Includes full construct sequence, CRISPR guide designs, pathway edit specifications, flux balance analysis, and IFI validation data.

Already purchased?